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EFFECTIVENESS OF PLATELET- RICH FIBRIN WITH BETA TRI-CALCIUM
PHOSPHATE PLUS CALCIUM SULFATE ON PERIODONTAL INTRABONY DEFECT
MANAGEMENT (RANDOMIZED CONTROLLED CLINICAL STUDY)
Abstract
The purpose of this study is to evaluate the effectiveness of beta tri-calcium phosphate plus calcium
sulfate mix, with or without platelet rich fibrin in reducing probing periodontal pockets clinically and
defect depths radiographically, while increasing clinical attachment levels to reconstruct intrabony defects
in human clinical trials. Materials and Methods: Sixteen participants with periodontal intrabony defects
≥ 5 mm were divided into two equal groups. The first eight intrabony defects in study group received
platelet rich fibrin mixed with EthOss ®; while the eight remaining intrabony defects in control group were
reconstructed only with EthOss® synthetic bone substitute. Freidman ANOVA and Mann-Whitney tests
were chosen for intra-group and inter-group comparisons, respectively. Results: Final outcomes revealed
statistically significant decrease in periodontal pocket depth and defect depth values (P ˂ 0.05) with a
statistically significant clinical attachment level gain in study and control groups. Precisely, mean values of
all measured categories were greater in study rather than control group participants, as confirmed clinically
by William’s probe and radiographically by cone-beam computed tomography at 6 months after surgery.
Conclusion: Adding PRF to β-TCP plus CS is highly effective in inducing new periodontal soft and hard
tissue synthesis resulting in better clinical and radiographic outcomes when surgically incorporated in
periodontal intrabony defect(s).
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1. INTRODUCTION
Calcium sulfate CS is an antimicrobial, bacteriostatic and osteoconductive biomaterial that
can induce formation of new blood vessels by chemotaxis of platelets at wound site and can
differentiate periodontal ligament PDL fibroblasts into osteoblasts and cementoblasts prior to its
complete dissolution. Some colleagues incorporated CS to carry antibiotics and growth factors
GFs necessary to close postsurgical cystic gaps, conserve alveolar ridges, build three-walled
bone defects and fill class II furcations (Mukherji et al., 2016). However, recent studies
discussed the effect of CS dissolution on decreasing the pH of grafted area with more GFs and
subsequent bone morphogenic proteins’ release. This also induced mesenchymal cells to
differentiate into bone forming cells and enhanced gene expression to control osteoblastic
behavior (Fernandes et al., 2021).
Following periodontal surgery, cells normally populate from adjacent gingival epithelium,
gingival connective tissue, alveolar bone and PDL to the healed wound, for new periodontal
apparatus formation. Also platelets aggregate at wound site with fibrin formation to initiate
release of GFs (Giannobile,1996).
In previous works, combination of beta tri-calcium phosphate β –TCP with platelet-rich
fibrin PRF stabilized blood clots for a long duration, enhanced early bone formation, remodeling
and mineralization (Sunitha & Munirathnam, 2008). As to increase quantity of leukocytes,
platelets and GFs, the low speed centrifugation concept was introduced to conventional PRF
protocol for better tissue regenerative outcomes (Choukron & Ghanaati, 2018). Although few
researchers reported positive outcomes in intrabony defects IBDs filled with PRF plus xenograft
mix; better clinical and radiographic defect fills were documented using PRF plus allografts
(Atchuta et al., 2020).
EthOss® is a bioactive synthetic alloplast composed of 65% β-TCP and 35% CS that can
be easily manipulated and adapted to IBD after mixing with saline or patient’s own plasma to
provide a scaffold for newly formed bone (Leventis et al., 2020). Mukherji et al., in (2016),
related absence of inflammation at surgically grafted sites in study and control groups to
bacteriostatic potential of fully dissoluted CS and resultant lower pH at grafted site. However,
Gao et al. in (2016) focused on the role of calcium ions liberated from resorbable CS in
providing a pool for bone mineralization.
Previous researchers also combined CS to β-TCP without collagen membrane to enhance
the biomechanical properties of β-TCP, speed up new bone maturity, improve wound healing
and reduce economic expenses on patients (Sukumar et al., 2010). In 2020, Leventis et al. related
success of EthOss® in filling IBD to variations in particle size, porosity and resorption rate of
both CS and β-TCP.
Based on the abovementioned literature, this earned our interest to undertake this research.
The aim of the study is to evaluate clinically and radiographically the effectiveness of plateletrich fibrin mixed with beta tri-calcium phosphate plus calcium sulfate, in regeneration of
periodontal intrabony defect as regards clinical probing pocket depth and clinical attachment
level CAL at 3 and 6 months respectively.

2. MATERIALS AND METHODS
2.1 Study Design
This randomized controlled clinical trial was carried out after obtaining the validation
of Institutional Review Board IRB at Beirut Arab University, IRB approval number: 2020H-0079-D-M-0418. Suitable candidates were chosen from the Department of Oral Surgical
Sciences, Periodontology Specialty Clinics at Beirut Arab University, according to latest
periodontitis classification approved by American Academy of Periodontology, precisely
stages (II/ III) and grades (A/B) (Tonnetti et al., 2018).

Published by Digital Commons @ BAU, 2022

1

BAU Journal - Creative Sustainable Development, Vol. 4, Iss. 1 [2022], Art. 8

Medical history was recorded and complete blood count was carried out for all
patients at baseline to rule out any obstacles that may hinder bone healing in surgical sites.
A written informed consent was signed by each patient, following verbal explanation of all
treatment procedures.
Phase one therapy was carried out for all patients including coronoplasty if needed.
Proper oral hygiene instructions were also advised for (4-6) weeks. Then, probing pocket
depth measurements of teeth were rechecked by marked William’s periodontal probe.
Clinical cases with periodontal pocket depths ≥ 5 mm and angular bone loss in patients
compliant to planned follow ups at 3 months and 6 months were selected.
Aided by computerized randomization, Randomizer.org was used to allocate sixteen
healthy patients, with clinical and radiographical periodontal pocket depth value ≥ 5 mm, in
two equal groups (n=8) to be treated respectively by EthOss®/PRF mix and EthOss®
alloplast.

2.1.1 Study group
Eight patients involved with IBD, were subjected to full thickness fully reflected
mucoperiosteal flaps, followed by packing (EthOss®/ PRF) mix in such defects. The
flap was closed by tension free interrupted sutures.

2.1.2 Control group
Eight patients with IBD were subjected to full thickness fully reflected
mucoperiosteal flaps to incorporate EthOss® graft at intrabony defective areas. The
flap was secured in its place via interrupted sutures.

2.2 Inclusion Criteria
1)
2)
3)
4)
5)

Clinically healthy participants, with no distinction in gender.
Age range (30-55) years.
Non-smokers or light smokers (˂ 5 cigarettes /day).
Plaque index cases ≤ 20%.
Adequate zone of attached gingiva

2.3 Exclusion Criteria
1)
2)
3)
4)
5)
6)
7)

Hypertensive patients.
Uncontrolled diabetics.
Immune-compromised patients.
Pregnant or lactating mothers.
Patients on anticoagulant therapy or with bleeding disorders.
Patients with any systemic disease that may affect bone healing.
Patients with parafunctional habits

2.4 Stent Fabrication
For precise standardization of clinical measures, a (2-3) mm thick customized, cold
cured acrylic stent was formed after casting registered alginate impressions of arches
including IBD. These stents covered the occlusal and the coronal one third of labial/ buccal
and lingual/ palatal surfaces of teeth related to intra bony defects in study and in control
groups (Singh & Vandana, 2019).

2.5 Radiographic Evaluation
At baseline, panoramic x-rays were performed to all suitable candidates. Applying
long cone paralleling technique and using Sopix² RVG placed in Rinn XCP-DS®
FIT™ digital sensor holding device, periapical radiographs of teeth with IBD were executed
preoperatively and after 3 months.
Moreover, a digital grid millimeter scale software system in computerized cone-beam
computed tomography CBCT of selected quadrants with IBD interpreted the measures
between three fixed points at baseline, as presented in Fig. 2(a) & Fig. 3(a) and at 6 months
post operatively, as shown in Fig. 2(b) & Fig. 3(b) to execute the amount of newly formed
bone along tooth’s root surface adjacent to IBD, known as linear bone fill LBF. These fixed
points were defect base DB, cement-enamel junction CEJ and bone crest BC. Precisely, DB
https://digitalcommons.bau.edu.lb/csdjournal/vol4/iss1/8
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is the deepest radiographic bony mark adjacent to healthy PDL space width in IBD involved
tooth. CEJ represents the anatomical meeting point between tooth enamel and its root
cementum and BC is the most coronal portion of inter proximal alveolar bone contacting
tooth’s root lateral to IBD (Oh et al., 2019).

2.6 Platelet -Rich Fibrin Protocol Preparation
One sample of 10 ml intravenous blood was withdrawn from the superficial vein in
the Cubital Fossa into plain glass tubes without any anticoagulant. Within 1 minute, this
tube was placed in centrifugation machine (Champion® F-33D) and was balanced by an
opposing saline filled glass tube, prior to program running at 3000 RPM /15 minutes at
room temperature. At the end of spinning cycle, the collected tubes showed a top plasma
liquid layer, a middle gel fibrin rich layer called PRF and a bottom erythrocyte layer (Saluja
et al., 2011) as presented in Fig.1.

Fig.1: Collection of (PRF) gel from plain glass test tube after blood
sample centrifugation.
Reference: Photographed by the author.

2.7 Surgical Technique
All surgical procedures were performed under complete aseptic and sterile
conditions. At the selected quadrant, an antiseptic septidyne® swab was applied extra-orally
and intra-orally. Then, (2%) local anesthetic solution was locally infiltrated. In study and
control groups, minimally invasive intrasulcular and interdental papillary preserved
incisions around teeth involved and adjacent to IBD were executed with a pen grip, using a
15C blade projected on Bard Parker scalpel handle #3.
By a Molt #9 periosteal elevator, an envelope shaped, full thickness mucoperiosteal
flap was bluntly dissected and reflected buccally/ labially (2-3) mm beyond mucogingival
junction in addition to full thickness flap reflection of surgical site lingually/ palatally. In
both groups, proper removal of the subgingival granulation tissues and thorough root
planning were done with After Five® Gracey, site specific curettes. Local saline irrigation
was done copiously. Root conditioning using 10% citric acid.
For study group: Superficial plasma in test tubes was aspirated in a 3 ml disposable
plastic syringe, to hydrate dry alloplastic bone graft after gentle tapping. At the same time,
Published by Digital Commons @ BAU, 2022
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the bioactive part of PRF was chopped via #16 Goldman Fox surgical scissors and slowly
mixed, within 3 minutes, in sterile PRF bowl with dry EthOss® powder moistened by
patient’s own plasma. Then, a mix of PRF and EthOss® was carried to surgical area,
incrementally, with Lucas curette.
For control group: Depending on the size of bone defect, 0.5 cc or 1 cc of EthOss®
bone graft was dispensed in a sterile, stainless steel dappen dish to be mixed with an equal
volume of sterile 0.9% saline solution until a flexible paste was obtained and carried to
surgical quadrant with Lucas curette to fully pack IBD.
In both groups, gentle application of the prepared bone graft to the intraosseous
defect till its bony crest was achieved with an amalgam plugger (3T-Tanner). Final
readaptation and closure of mucoperiosteal flap was done with tension free, interrupted, Dtek® sutures, made up of nonresorbable polypropylene threads, size 4/0.

2.8 Postsurgical Care
Each patient was advised to quit biting and/ or tooth brushing on the surgically
restored quadrant and to take soft food in the first 2 weeks, plus prescribed medications as
Amoxil® 500 mg TID for 5 days, Brufen® 400 mg BID for 3 days and Paroex®
mouthwash composed of Chlorhexidine Gluconate (0.12%) for 1 minute, BID for 10 days
starting from the 3rd day after surgery (Sadiq et al., 2020).

2.9 Postsurgical Follow up
Within 2 weeks, all interrupted synthetic sutures were removed. Supra gingival
scaling was only performed at 3 months and 6 months. Oral hygiene instructions were
readvised. Numerical changes in PPD and CAL were recorded at previous calls to the
nearest millimeter by a single examiner, using William’s periodontal probe in relation to the
customized occlusal acrylic stent. Radiologic follow ups were monitored by digital
periapical radiography of teeth in IBD via parallel long cone technique at 3 months and
CBCT at 6th month post-surgery as presented in Fig. 2(b) & Fig. 3(b).

Statistical Analysis
This randomized clinical trial was executed equally on maxillary and mandibular teeth.
All clinical and radiographic parameters were recorded in study and control groups, at baseline,
3 months and 6 months. The mean and standard deviation of collected data of all categories were
assessed and compared by Freidman ANOVA and Mann-Whitney tests. Using a computerized
IBM® Software, final data analysis was processed by the Statistical Package for Social Sciences
SPSS version 24.
Categories with P values less than 0.05 (P ˂ 0.05) were considered statistically significant.

3. RESULTS
3.1 Intra-Group Comparisons: (Freidman ANOVA Test)
3.1.1 Study group
A statistically significant reduction of mean periodontal pocket depth with a P
value = 0.0003 at 3rd and 6th months following surgery.Mean clinical attachment
level values scored statistically significant change at 3rd and 6th months with a P value
= 0.001. Moreover, mean defect depth amounts were significantly lowered with a P
value = 0.0003 at 3rd and 6th months as in Table 1.

3.1.2 Control group
Calculated mean of PPD scores recorded at 3rd month following periodontal
surgery showed a minimal reduction. Yet, at 6th month a statistically significant
reduction of mean PPD was noted with P value = 0.003. Minor suppression in mean
CAL values was noted at 3rd month post surgery. But, a statistically significant
decrease in mean CAL scores was recorded at 6th month after surgery with a P value
= 0.002. Also, a negligible reduction in mean DD was noted at 3rd month compared to
a statistically significant reduction in mean DD was clear at 6th month with a P value
= 0.00044 as presented in Table 1.
https://digitalcommons.bau.edu.lb/csdjournal/vol4/iss1/8
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Table 1: Intra-group comparisons at baseline, 3 months and 6 months (Freidman
ANOVA test)
Baseline (mm)

3 months (mm)

6 months (mm)

P value

Periodontal pocket depth (PPD)

9.00 ± 0.92

7.00 ± 0.92

5.00 ± 0.75

0.0003*

Clinical attachment level (CAL)

8.00 ± 0.92

7. 00 ± 0.92

5.80 ± 0.99

0.001*

Depth of the defect (DD)

8.00 ± 0.75

6.75 ± 0.70

5.00 ± 0.53

0.0003*

Periodontal pocket depth (PPD)

7.00 ± 0.75

7.00 ± 0.53

6.00 ± 0.53

Category Mean

Study group

0.003*
Control Group

Clinical attachment level (CAL)

7.00 ± 0.92

6.875±0.83

6.125 ± 0.83

0.002*

Depth of the defect (DD)

6.12 ± 0.83

6.00 ±0.75

5.00 ± 0.75

0.00044*

*Denotes statistically significant difference

3.2 Inter-group Comparisons: (Mann-Whitney Test)
3.2.1 Differences in mean category measures at baseline and at 3 months:
To determine if there is a statistically significant difference between results
obtained from control and study groups at 3 months of surgery, measures of PPD,
CAL and DD means obtained at 3 months and at baseline were first subtracted and
the resulting differences were executed prior to performing Mann-Whitney test. P
values less than 0.05 (P ˂ 0.05) were statistically significant.
The executed results were related to the following categories:
1- Periodontal pocket depth: The calculated outcomes noted U-test = 1 and a
statistically significant difference between the variations in mean PPD observed in
control and study groups, P = 0.001. Also, variations in mean rank indicated that
values of difference between mean PPD values in case of study group were higher
than those in control group as shown in Table 2.
2- Clinical Attachment Level: The results obtained marked U-test = 4 plus a
statistically significant difference among the variations in mean CAL in control
and study groups with P value = 0.001. Moreover, variations in mean rank
emphasized that values of difference between mean CAL values in study group
were higher than in control group as clarified in Table 2.
3- Depth of Defect: The applied tests on collected data proved a statistically
significant difference in mean DD variations observed between control and study
groups with P value = 0.0008. However, variations in mean rank assured that
differences within mean DD scores were higher in study group compared to
control group as presented in Table 2.

Published by Digital Commons @ BAU, 2022
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Table 2: Inter-group category comparisons at baseline and at 3 months (Mann-Whitney
U-test)
M ann-Whitney U Test

M ean Rank

Periodontal pocket
depth (PPD)

Control group

4.63

Study group

12.38

Difference between
Control group
Clinical attachment
measure at baseline and
level (CAL)
after 3 months
Study group

Depth of the defect
(DD)

U-test

P value

1

0.001*

4

0.001*

3

0.0008*

5
12

Control group

4.88

Study group

12.13

*Denotes statistically significant difference

3.2.2 Differences in mean category measures at 3 months and at 6 months:
To determine if there is a significant difference between results in control
versus study groups between 3rd and 6th month post-surgery, mean category values at
6th month were subtracted from corresponding values at 3rd prior to performing
Mann-Whitney U-test for categories as:
1- Periodontal pocket depth: Results listed in Table 3 showed U-test = 8 with P value
= 0.003 that signified a statistically significant difference in mean PPD between
variations observed in control and study groups. Whereas, variations in mean rank
indicated that values of difference among mean PPD measures in study group
were higher than that obtained in control group.
2- Clinical attachment level: Related outcomes detected values of U-test = 24 and P
value = 0.369 which indicated no significant difference in mean CAL variations
between control and study groups as shown inTable3.
3- Depth of defect: Scores recorded U-test = 16, while P value = 0.0027 that
demonstrated a statistically significant difference in mean DD variations among
study and control groups. Also, variations in mean rank assured that difference in
mean DD values were higher in study group compared to control groups as
clarified in Table 3.
Table 3: Inter-group category comparisons at baseline and at 6 months Mann-Whitney
U- test)
M ann-Whitney U Test
M ean Rank

Periodontal pocket
depth (PPD)
Difference
between measure Clinical attachment
after 3 months and level (CAL)
after 6 months
Depth of the defect
(DD)

Control group

5.5

Study group

11.5

Control group

7.5

Study group

9.5

Control group

6.5

Study group

10.5

U-test

P value

8

0.003*

24

0.369

16

0.027*

*Denotes statistically significant difference

https://digitalcommons.bau.edu.lb/csdjournal/vol4/iss1/8
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3.2.3 Differences in mean category measures at baseline and at 6 months:
To determine if there is a significant difference between results in control
versus study groups at 6 months after surgery, mean category values at 6th month
were subtracted from those at baseline prior to performing Mann-Whitney U-test for
PPD, CAL and DD categories below:
1- Periodontal pocket depth: Results indicated that U-test = 0 with P value = 0.0003
affirmed a statistically significant difference between variations in mean PPD
observed in study and control groups. Moreover, mean rank values signified that
difference between mean PPD in case of study group was higher than those in
control group as shown in Table 4.
2- Clinical attachment level: Executed outcomes marked U-test = 10 and P value =
0.009 confirmed a statistically significant difference between variations in mean
CAL observed in control and study groups. While, mean rank scores emphasized
that difference between mean CAL in study group were higher than in control
group as listed in Table 4.
3- Depth of defect: Calculated measures noted U-test = 1.5 and P value = 0.001
proved statistically significant difference between variations in mean DD in
control and study groups. Moreover, mean rank values assured that the difference
between mean DD in study group was higher than in control group as presented
in Table 4.
Table 4: Inter-group category comparisons at baseline and at 6 months (Mann-Whitney
U-test)
M ann-Whitney U Test

M ean Rank

Periodontal pocket
depth (PPD)

Difference between
measure at baseline
and after 6 months

Clinical attachment
level (CAL)

Depth of the defect
(DD)

Control group

4.5

Study group

12.5

Control group

5.81

Study group

11.19

Control group

4.69

Study group

U-test

P value

0

0.0003*

10

0.009*

1.5

0.001*

12.31

*Denotes significant difference

3.2.4 Radiographic bone fill at 6th month after surgery:
Linear bone fill LBF was estimated from the difference of DD measured by
CBCT of quadrants involved with IBD between 6 months and baseline. Finally,
mean linear bone fill percentage was executed. These values were 37% in study
group and 18.39% in control group as shown in Table 5.
Table 5: Mean linear bone fill percentage at 6 months post surgery

Mean of percentage of linear
bone fill after 6 months

Published by Digital Commons @ BAU, 2022
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1- In Study group:

Fig.2: CBCT of lower right quadrant showing first molar with distal defect depth equals to
9.0 mm at baseline (a) and 5.0 mm at 6 months after surgery (b).
Reference: Photographed by the author.

2- In Control group:

8

Fig. 3: CBCT of upper right quadrant showing second molar with defect depth measures
of 8.0 mm mesially & 7.0 mm distally at baseline (a) and 6.0 mm on mesial & distal root
surface at 6th month post surgery (b).
Reference: Photographed by the author.

4. DISCUSSION
Beta tri-calcium phosphate is an alloplastic synthetic bone graft which is now used
extensively for bone defects. It is a bioactive and biocompatible material. It is made up of
calcium and phosphorous ions, the main components of bone. It can fully resorb and create many
pores to enhance new bone formation and subsequent graft replacement within the defect.
Calcium sulfate is an osteoconductive bone graft that resembled cell occlusive membrane rich in
calcium ions for bone mineralization.
PRF was preferred over platelet rich plasma PRP due to its cheaper cost, shorter
production time and longer duration of liberated GFs without incorporating any synthetic or
anticoagulant materials. PRF also provided stem cells and acted as scaffold for tissue cellular
attraction to injured site.
The results observed in this randomized clinical trial showed intra-group mean PPD
values diminished from baseline by about 2 mm and 4 mm respectively at 3rd and 6th month
intervals in study group. Meanwhile, intra-group mean PPD reduction of about 0.3 mm and 1
mm were recorded in control group at 3 and 6 months after surgery. Thus, mean PPD shrinkage
was higher in study versus control groups with an inter-group variation of approximate 1.7 mm
at 3 months and about 3 mm at 6 months.
https://digitalcommons.bau.edu.lb/csdjournal/vol4/iss1/8
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Relatively, gain in mean CAL executed within same group approached 1 mm at 3 months
and was doubled to 2 mm in study at 6 months. Yet, gain in mean CAL was 0.1 mm at 3 months
compared to about 1 mm surplus in mean CAL at 6 months in control group. Hence, mean CAL
gain was higher in study versus control group with approximate relative variation of 0.9 mm at 3
months and 1 mm at 6 months.
In addition, mean DD suppressed by about 1 mm and 3 mm in study group, whereas mean
DD reduction scored 0.1 mm and 1.1 mm in control group at 3 and 6 month intervals
respectively. So, mean DD reduction was higher in study group rather than in control with an
estimate of 0.9 mm and 1.9 mm, respectively at 3rd and 6th month intervals. However, linear bone
fill was greater in study group than in control groups. Precisely, mean linear bone fill’s
percentage in study group was double than that in control group when calculated at 6 months
after surgery.
Similar results were proved in previous studies. As PPD reduction of 4.55 mm ± 1.87, at
6th month after PRF sole incorporation in IBD (Sharma & Pradeep, 2011). This is in accordance
with another study executed by Pavaniet al. (2021) with a reduction in PPD of 4.3 mm ± 0.73
and bone fill range of 2.51 mm ± 0.97, when PRF and β-TCP were utilized in IBD, after 6
months.
Past controversies about reconstructing IBD with sole or combined PRF with biomaterials
were proved by some colleagues. Rosama et al. (2012) confirmed stable CAL increase by 3.36
mm ± 0.38 with PPD inter-group difference of 2.29 mm ± 0.3in PRF group, 9 months post
surgically. Similarly, Bajaj et al. (2013) confirmed a reduction in PPD in PRF study group of
4.29 mm ± 0.04 compared to control group 1.58 mm ± 1.02, plus CAL gain of 2.87 mm in study
group compared to 1.37 mm in control group, 9 months post operatively. This proved that PRF
could induce cellular chemotaxis, strewing and mitosis for rapid wound healing as it could aid in
mineralization of newly deposited bone for better quality of regenerated periodontium.
Navageni et al. (2015) related the cause of PPD reduction and CAL gain in PRF group to
high amounts of leukocytes present in fibrin clot, subsequent growth factor release, immune
regulation, angiogenesis and new bone fill. Similarly, Miron et al. (2017) advised incorporating
PRF in IBD due to its unique composition of platelets, leukocytes, cytokines and structural
glycoproteins. According to Liu et al. (2019), osteoblastic cell replication before PDL fibroblasts
and dental follicle progenitors caused bone fill of IBD by PRF.
Many clinical trials incorporated PRF in periodontal regeneration, with different
outcomes. All IBD filled with PRF documented gradual bone synthesis at 6, 9 &12 months. On
radiographs, this fill resembled natural bone (Nagaveni et al., 2015). Galav et al. (2016)
confirmed superiority of autogenous bone grafts over PRF in IBD fill at 9 months. In contrast,
some colleagues proved stability of new bone in IBD filled with EthOss® for two years post
surgery (Leventis et al., 2020).
PRF had limited osteogenic potential, due to its quick resolution. Such drawback
necessitated modifications to sole PRF use, by adding bone grafts or drugs to PRF for better
quantitative intrabony defect refill as reported by Lei et al. in (2019) and Liu et al. in (2019).

5. LIMITATIONS OF THIS STUDY
One of the clinical limitations is variety of produced PRF gel among patients due to
tendency of blood to coagulate rapidly in test tubes after 1-2 minutes. Hence, any further delay
in handling time may yield to a rapidly degradable fibrin clot and subsequent poor tissue healing.
The other limitation is undesirable centrifugation machine vibrations that may cause alteration in
PRF’s 3D structure, cellular to fibrin ratio and release of GFs. This requires standardization of
PRF quantity for best clinical and radiographic outcomes. In addition, enrolling a limited number
of 16 participants, within a 6-months observation period, makes evaluating collected data futile.
In the light of these facts, further long-term clinical trials with bigger sample size are
recommended to measure further improvements in clinical and radiographical parameters for 12
months duration and to check stability of newly formed periodontium.

Published by Digital Commons @ BAU, 2022

9

BAU Journal - Creative Sustainable Development, Vol. 4, Iss. 1 [2022], Art. 8

6. CONCLUSIONS
Introducing PRF is safe and effective in empowering the osteogenic potential of β-TCP
plus CS. Moreover, absence of any undesirable antigenic reaction to hard or soft tissues
confirmed patient’s comfort and clinical safety of this alloplastic/ PRF mix. Hence,
incorporating PRF to a composite bone grafts in IBD ≥ 5 mm boosted PPD reduction, CAL gain
with marked radiographic linear bone refill in study group rather than in control group at 6
months post surgically.
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